First real success for anti-HIV gel: a new start for HIV microbicides?
Kevin K
KK
Ariën
Guido
G
Vanham
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D000293:Adolescent; D000328:Adult; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000009:adverse effects; D018849:Controlled Clinical Trials as Topic; D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D063065:Organophosphonates / Q000008:administration & dosage* / Q000494:pharmacology; D015229:Sexually Transmitted Diseases, Viral / Q000517:prevention & control*; D013019:South Africa; D000068698:Tenofovir; D016896:Treatment Outcome; D014622:Vaginal Creams, Foams, and Jellies / Q000008:administration & dosage* / Q000009:adverse effects; D055815:Young Adult
D000890:Anti-Infective Agents; D063065:Organophosphonates; D014622:Vaginal Creams, Foams, and Jellies; D000068698:Tenofovir; D000225:Adenine